Page last updated: 2024-08-17

4-nitroquinoline-1-oxide and crizotinib

4-nitroquinoline-1-oxide has been researched along with crizotinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Naggar, AK; Fan, YH; Feng, L; Foy, JP; Hong, WK; Kim, ES; Lang, W; Lee, JJ; Lingen, MW; Lippman, SM; Mao, L; Papadimitrakopoulou, V; Saintigny, P; William, WN; Zhang, L	1

Trials

1 trial(s) available for 4-nitroquinoline-1-oxide and crizotinib

Article	Year
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. Journal of the National Cancer Institute, 2018, 03-01, Volume: 110, Issue:3 Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cell Proliferation; Crizotinib; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Genomics; Head and Neck Neoplasms; Humans; Leukoplakia, Oral; Male; Mice, Inbred CBA; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Invasiveness; Precancerous Conditions; Prognosis; Prospective Studies; Proto-Oncogene Proteins c-met; Pyrrolidinones; Quinolines; Quinolones; Survival Rate; Tumor Cells, Cultured	2018

Article

Year

Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.

Journal of the National Cancer Institute, 2018, 03-01, Volume: 110, Issue:3

Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cell Proliferation; Crizotinib; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Genomics; Head and Neck Neoplasms; Humans; Leukoplakia, Oral; Male; Mice, Inbred CBA; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Invasiveness; Precancerous Conditions; Prognosis; Prospective Studies; Proto-Oncogene Proteins c-met; Pyrrolidinones; Quinolines; Quinolones; Survival Rate; Tumor Cells, Cultured

2018